Frailty in Older people: Rehabilitation Treatment Research Examining Separate Settings PLUS. (FORTRESS Plus)
- Conditions
- FrailtyPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitation
- Registration Number
- ACTRN12623001103651
- Lead Sponsor
- Hornsby Ku-ring-gai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 106
To be eligible to participate in the FORTRESS Plus Study, people must be:
Aged 70 years and over.
Admitted to the study wards at Hornsby Ku-ring-gai Hospital (2D, 3D and 4D)
Assessed as frail (using the FRAIL Scale Risk Assessment Tool) by the FORTRESS Clinician (scored 3 or greater on this scale)
Reside at home in the community within the NSLHD catchment area (i.e., do not reside in a Residential Aged Care Facility)
Have achieved a score of 22 or more on the MMSE (in the last 2 months)
Be English speaking.
The following patients will be excluded from the FORTRESS Plus study:
People admitted to hospital with a new stroke (during the indexed admission).
People who are not frail (i.e., score less than 3 on the FRAIL Scale)
People who have an estimated life expectancy of less than 12 months (as determined by The Illness Severity Rating Scale)
People who are unable to cooperate with an intervention program.
People aged less than 70 years.
Those unable to walk without the assistance of one other person.
Anyone who resides in a Residential Aged Care Facility
Participants who were recruited into the FORTRESS study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of Life [EQ-5D-5L and Visual Analogue Scale Baseline, 4 months post recruitment, 12 months post recruitment.]
- Secondary Outcome Measures
Name Time Method Frailty Status [FRAIL scale Baseline, 4 months post recruitment, 12 months post recruitment.];Physical Outcomes[Short Physical Performance Battery Test (SPPB) Baseline (initial home visit), 4 months and 12 month outcome assessment time points]